Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michelino De Laurentiis
Observed names:
M De Laurentiis,
M. De Laurentiis
Institutions:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Scuola Superiore Meridionale,
Temple University
Observed institutions:
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale",
Scuola Superiore Meridionale,
Temple University
ORCID:
0000-0001-9009-1572
Observed ORCID:
0000-0001-9009-1572
OpenAlex ID:
A5136460473
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
2026
·
R. Dent
, Z. Shao
, et al.
·
Annals of Oncology
·
58
Dual Paper-Based Electrochemical Device for Multiplex Detection of Triple-Negative Breast Cancer miRNA Signatures
2026
·
Alessandra Glovi
, Panagiota M. Kalligosfyri
, et al.
·
Analytical Chemistry
·
6
PDF
Time-of-day administration of immunotherapy in early-stage triple-negative breast cancer: Immune-dependent chronotherapy effects in the phase III A-BRAVE trial.
2026
·
Maria Vittoria Dieci
, Davide Massa
, et al.
·
Journal of Clinical Oncology
·
3
Strengths and pitfalls of NNT and NNH in early breast cancer escalation trials
2026
·
Roberto Buonaiuto
, Federica Pia Mangiacotti
, et al.
·
The Breast
·
2
The effects of Mediterranean diet, physical activity, and vitamin D on breast cancer recurrence and cardiometabolic health: A multicenter randomized trial.
2026
·
Livia Augustin
, Vincenzo Di Lauro
, et al.
·
Journal of Clinical Oncology
·
2
Long-term responders to sacituzumab govitecan in metastatic triple-negative breast cancer: Real-world outcomes and predictors from a multicenter Italian cohort.
2026
·
Roberta Caputo
, Giuseppe Buono
, et al.
·
Journal of Clinical Oncology
·
1
Biosensors for Circular RNA Profiling in Biological Matrices
2026
·
Alessandra Glovi
, Panagiota M. Kalligosfyri
, et al.
·
Analytical Chemistry
PDF
Effect of GLP-1 receptor agonism on anthracycline- and HER2-targeted therapy–induced cardiac dysfunction and systemic inflammation in non-diabetic preclinical models.
2026
·
Vincenzo Quagliariello
, Annabella Di Mauro
, et al.
·
Journal of Clinical Oncology
Effects of SGLT2 inhibitor dapagliflozin on anticancer resistance and alpelisib- and fulvestrant-induced cardiomyocyte injury under hyperglycemic conditions.
2026
·
Vincenzo Quagliariello
, Massimiliano Berretta
, et al.
·
Journal of Clinical Oncology
ELEGANT: Elacestrant (Ela) Versus Standard Endocrine Therapy (ET) in Patients (Pts) With Node-positive, Estrogen Receptor-positive (ER+), HER2-negative (HER2-), Early Breast Cancer (eBC) With High Risk of Recurrence in a Global, Multicenter, Randomized, Open-label Phase (Ph) 3 Study
2026
·
M Graeser
, A Bardia
, et al.
·
Senologie - Zeitschrift für Mammadiagnostik und -therapie
483P Sacituzumab govitecan in older patients with advanced triple-negative breast cancer: Effectiveness and tolerability in real-world Italian practice
2026
·
G. Buono
, M. Piezzo
, et al.
·
ESMO Open
678eTiP A multimodal and multicenter approach for biobanking of biological materials and associated clinical data to improve rehabilitation in breast cancer patients with cognitive impairment – COMBINE
2026
·
R. Di Monda
, A. Calabrese
, et al.
·
ESMO Open
Show more works
View as search
Works count:
12
Citation count:
72
H-index:
3
I10-index:
1
Year
Topic
Type